Skip to content

Can you stay on Contrave for life? What to Know About Long-Term Use

4 min read

According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Contrave is one of several medications approved by the FDA for chronic, long-term weight management. This means that for some individuals, the answer to 'Can you stay on Contrave for life?' is yes, under a doctor's supervision, as part of a broader health plan.

Quick Summary

Contrave is an FDA-approved prescription for chronic weight management, but its long-term use requires ongoing medical supervision. Factors like effectiveness, tolerability, and associated health risks, including blood pressure and heart rate changes, must be monitored regularly.

Key Points

  • FDA Approval: Contrave is FDA-approved for chronic, long-term weight management in adults with obesity or overweight and weight-related comorbidities.

  • Conditional Long-Term Use: Staying on Contrave for life depends on individual effectiveness, tolerability, and requires continuous medical supervision to manage side effects and risks.

  • Initial Efficacy Check: If a patient hasn't lost at least 5% of their body weight after 12 weeks on the maintenance dose, the medication should be discontinued as it is unlikely to be effective.

  • Ongoing Monitoring: Regular checks for elevated blood pressure and heart rate are necessary, especially during the initial months of treatment.

  • Black Box Warning: Contrave carries a boxed warning for increased risk of suicidal thoughts and behaviors due to its bupropion component, requiring careful mental health monitoring.

  • Lifestyle Combination: The medication is not a 'magic bullet' and works best when combined with a reduced-calorie diet and regular exercise for sustained results.

  • Long-Term Cardiovascular Safety: A recent real-world evidence study (INFORMUS) found no increased cardiovascular risk in Contrave users, though monitoring remains important.

In This Article

The Role of Contrave in Chronic Weight Management

Contrave is a prescription medication designed to help certain adults with obesity or overweight, combined with weight-related health problems, achieve and maintain weight loss. The medication contains two active ingredients: naltrexone and bupropion. Naltrexone is an opioid antagonist typically used to treat alcohol and opioid dependence. Bupropion is an antidepressant that affects neurotransmitters in the brain. By combining these two medications, Contrave works on the brain's reward system to help reduce cravings and control appetite. It is important to note that Contrave is not a stand-alone treatment; it is most effective when used in conjunction with a reduced-calorie diet and increased physical activity.

When is Long-Term Contrave Use Appropriate?

For many individuals, obesity is a chronic condition that requires ongoing management. The FDA has approved Contrave for chronic, or long-term, weight management, provided the treatment is safe and effective for the patient. A key checkpoint for determining long-term suitability occurs early in treatment. If a patient does not achieve at least a 5% weight loss after 12 weeks at the recommended maintenance dose, a doctor will likely discontinue the medication. This initial screening ensures the drug is working before committing to an extended treatment plan. For those who respond positively, long-term use can be a viable option under continued medical guidance.

Monitoring and Safety Considerations for Long-Term Contrave Use

Ongoing medical supervision is critical for anyone on long-term Contrave therapy due to potential side effects and health risks.

Cardiovascular Monitoring

  • Blood Pressure and Heart Rate: Contrave can cause an increase in blood pressure and heart rate, especially during the first three months of therapy. It is crucial that healthcare providers check a patient's blood pressure and heart rate before starting and throughout the treatment. Contrave is contraindicated in patients with uncontrolled hypertension.
  • Cardiovascular Risk: A large, real-world evidence study (INFORMUS) presented in 2024 showed no evidence of increased cardiovascular risk (MACE) in long-term Contrave users, which is reassuring for patients and providers. However, monitoring is still a necessary precaution.

Mental Health Monitoring

  • Suicidal Thoughts and Behaviors: Due to the bupropion component, Contrave carries a boxed warning regarding the risk of suicidal thoughts and behaviors, particularly in young adults. Patients and their families should be vigilant for any sudden changes in mood, behavior, or feelings, and report them to a healthcare provider immediately.
  • Mood Changes: Bupropion can trigger manic or depressive episodes in susceptible individuals. It is contraindicated in patients with a history of bipolar disorder.

Other Important Safety Precautions

  • Seizure Risk: Bupropion can cause seizures in a dose-dependent manner. Factors increasing this risk include a history of seizures or head trauma, and concomitant use of other seizure-lowering medications. It is essential not to exceed the recommended dose and to avoid taking it with high-fat meals.
  • Liver Health: In rare cases, Contrave can cause liver damage or hepatitis. Symptoms like persistent stomach pain, dark urine, or yellowing of the eyes should be reported to a doctor.
  • Opioid Interactions: Contrave must not be taken with opioids, as the naltrexone component can cause sudden opioid withdrawal. There must be a period of 7-10 days opioid-free before starting Contrave.

Managing Plateaus and Long-Term Effectiveness

For many, weight loss tends to slow down or plateau over time. This is a normal part of the weight loss journey and doesn't necessarily mean Contrave has stopped working. It's often a sign that metabolism is adapting to the lower body weight. During a plateau, a healthcare provider can work with the patient to adjust the overall weight management strategy. Continuing with diet, exercise, and Contrave can help sustain the weight loss achieved and combat the body's natural tendency to regain weight.

Alternatives for Long-Term Weight Management

If Contrave is not tolerated or ceases to be effective, several other long-term weight management medications are available.

Medication Name Brand Name How It Works Key Considerations
Semaglutide Wegovy® Mimics GLP-1 hormone to regulate appetite Weekly injection; higher average weight loss than Contrave; often more expensive
Tirzepatide Zepbound® Mimics GIP and GLP-1 hormones to regulate appetite Weekly injection; highest average weight loss in clinical trials; recent market entry
Liraglutide Saxenda® Mimics GLP-1 hormone Daily injection; lower average weight loss than Wegovy or Zepbound
Phentermine/Topiramate Qsymia® Combines appetite suppressant and anti-seizure medication Oral capsule; side effects can include insomnia, altered taste; birth defect risk
Orlistat Xenical® Inhibits fat absorption in the gut Oral capsule; OTC version available (Alli); requires low-fat diet; potential for gastrointestinal side effects

The Decision to Continue Contrave for Life

Staying on Contrave for life is a possibility for some patients, but it is not a decision to be taken lightly. It is a long-term commitment that requires consistent medical follow-up to monitor for safety and effectiveness. Patients should have regular check-ins with their doctor to evaluate their progress, discuss any side effects, and make adjustments to their overall weight management plan as needed. The ultimate goal of long-term weight management is to improve overall health and well-being, and medication is just one tool in a comprehensive strategy that includes diet, exercise, and behavioral therapy.

Conclusion

Ultimately, the ability to stay on Contrave for life is an individual medical decision made in consultation with a healthcare provider. The FDA has approved it for chronic use, recognizing that obesity is a long-term disease. However, this approval is conditional on ongoing monitoring for safety, effectiveness, and tolerance. For suitable patients who benefit from the medication and tolerate it well, Contrave can be a valuable component of a long-term strategy, alongside a reduced-calorie diet and increased physical activity. Regular medical check-ups are essential to manage potential side effects, monitor cardiovascular health, and assess mental well-being throughout the treatment duration. For more information on Contrave and its safety profile, please consult the official website.

Frequently Asked Questions

Yes, for some individuals, Contrave is approved for chronic (long-term) use as part of an ongoing weight management plan. However, this is determined by your doctor based on the medication's effectiveness and your ability to tolerate it over time.

The duration of Contrave treatment is variable and depends on your individual response. It can be a long-term medication, but your doctor will evaluate its effectiveness after 12 weeks. If you haven't lost at least 5% of your body weight by then, it is typically discontinued.

Weight loss plateaus can occur with any weight management strategy, including Contrave. If this happens, your doctor may suggest re-evaluating your diet and exercise plan. If overall weight loss remains insufficient, they might discuss alternative medications.

Potential long-term side effects can include increases in blood pressure and heart rate, as well as mental health changes due to the bupropion component. Regular monitoring of these factors by a healthcare provider is essential.

Contrave is not suitable for individuals with uncontrolled high blood pressure, a history of seizures, eating disorders, opioid dependence, or those taking MAO inhibitors.

Weight regain is a common concern after stopping weight management medication, as the body's metabolic adaptations can lead to increased hunger and decreased satiety. Continued dedication to lifestyle modifications is crucial to minimize regain.

Different long-term weight loss medications have distinct side effect profiles. Contrave is associated with nausea, constipation, headache, and mental health risks. Other drugs, like GLP-1 agonists (Wegovy, Zepbound), may cause more gastrointestinal issues, while Phentermine/Topiramate (Qsymia) carries risks for birth defects and heart problems.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.